Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2002
10/03/2002WO2002076438A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
10/03/2002WO2002062784A8 Piperidinee derivatives as neurokinin 1 antagonists
10/03/2002US20020143176 For therapy of diseases associdated with Factor VIIa and or inosine monophosphate dehydrogenase (IMPDH)
10/03/2002US20020143040 Having antipyretic action, analgesic action, anti-inflammatory action;side effect reduction
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143026 Induce mitotic arrest thereby making them useful as anti-cancer agents; also for therapy of diseases which can be treated by inducing mitotic arrest
10/03/2002US20020143024 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143014 Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
10/03/2002US20020143011 Tri-substituted phenyl derivatives and processes for their preparation
10/03/2002US20020143009 Novel bicyclic oxazolidinones as antibacterial agents
10/03/2002US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine
10/03/2002US20020142967 Thrombin inhibitors
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/02/2002WO2001077084A1 Substituted phenyluracils
10/02/2002EP1244658A2 Azolyl-alkyl azole derivatives, a method for their production and their use as pesticides
10/02/2002EP1244657A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/02/2002EP1244652A1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
10/02/2002EP1244648A1 Chemokine receptor binding heterocyclic compounds
10/02/2002EP1244637A1 Butyne diol derivatives
10/02/2002EP1244631A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
10/02/2002EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002EP1244627A1 Picolinic acid derivatives and their use as fungicides
10/02/2002EP1098894B1 Fkbp inhibitors
10/02/2002EP1047684B1 Substituted alpha,beta-anellated butyrolactones
10/02/2002EP0679641B1 Sulfonamide and sulfonic ester derivatives each having tricyclic hetero ring
10/02/2002DE10114597A1 Arylisoxazolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel Arylisoxazolin-derivatives, processes for their preparation and their use as pesticides
10/02/2002CN1372557A Neurotrophin production/secretion promoting agent
10/02/2002CN1372553A Novel thiazine or pyrazine derivatives
10/02/2002CN1372552A Pyrimidine derivatives and herbicides containing the same
10/02/2002CN1372549A Fungicidies
10/02/2002CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/02/2002CA2404759A1 Substituted phenyluracils
10/01/2002US6458830 The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis and postherpetic neuralgia.
10/01/2002US6458817 Aromatic substituted sufure or sulfoxide or sulfone derivatives containing seconday amine and hydroxy groups are useful in treatng metabolic disorders mediated by insulin resistance or hyperglycemia in mammals
10/01/2002US6458814 Vitronectin receptor antagonists and are useful in the treatment of osteoporosis: treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor,
10/01/2002US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002US6458805 Antagonists; especially sodium salts
10/01/2002US6458790 Substituted piperidines as melanocortin receptor agonists
10/01/2002US6458788 4-hydroxycinnoline-3-carboxyamides as antiviral agents
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458784 Vitronectin receptor antagonists
10/01/2002US6458783 Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
10/01/2002US6458474 Methine compound, material for organic luminescence element, organic luminescence element using the same
10/01/2002CA2241845C 4,5-dihydronaphth¬1,2-c|isoxazoles and derivatives thereof having cns activity
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002CA2089769C Heterocyclic compounds and their preparation and use
10/01/2002CA2059708C Indole derivatives
09/2002
09/28/2002CA2342432A1 Novel compound
09/27/2002CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/26/2002WO2002074768A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
09/26/2002WO2002074763A1 Benzimidazol derivatives modulate chemokine receptors
09/26/2002WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
09/26/2002WO2002074752A1 Metalloproteinase inhibitors
09/26/2002WO2002074750A1 Metalloproteinase inhibitors
09/26/2002WO2002074749A1 Metalloproteinase inhibitors
09/26/2002WO2002074743A1 Aryl-substituted alicyclic compound and medical composition comprising the same
09/26/2002WO2002074388A1 Bisarylamines as potassium channel openers
09/26/2002WO2002074296A1 Remedies for solid cancer containing hydroxamic acid derivatives as the active ingredient
09/26/2002WO2002074036A2 Substituted benzopyranones as telomerase inhibitors
09/26/2002WO2002055517A3 4-(hetero)aryl substituted indolinones
09/26/2002WO2002036116A3 Tripeptidyl peptidase inhibitors
09/26/2002WO2002032872A8 Nitrogenous aromatic ring compounds
09/26/2002WO2001072743A1 Triazole compounds having amide linkage
09/26/2002US20020137978 Using as catalyst ruthenium or osmium carbene complexes containing an imidazolidine ligand
09/26/2002US20020137955 Reaction of an oxazole compound, (phenylisoserine derivative) with a hydroxyl-protected Baccatin III derivative to produce a taxane substrate that can be used to form paclitaxel and other taxanes
09/26/2002US20020137932 Treating autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, and asthma
09/26/2002US20020137929 1 - (3-heterocyclylphenyl) isothiourea, -isourea, -guanidine and -amidine herbicidal agents
09/26/2002US20020137769 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
09/26/2002US20020137766 Electrophysiological activity
09/26/2002US20020137755 Tyrosine kinase inhibitors
09/26/2002US20020137745 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease
09/26/2002US20020137742 Benzenesulfonamide compounds
09/26/2002US20020137734 N-hydroxy-2-(2-(((4-((2-methyl-4-quinolinyl)methoxy)phenyl) -sulfonyl)methyl)-2-pyrrolidinyl)acetamide, for example and other quinoline containing N-hydroxyacetamide derivatives
09/26/2002US20020137664 Substituted piperidines as melanocortin-4 receptor agonists
09/26/2002CA2444526A1 Metalloproteinase inhibitors
09/26/2002CA2442268A1 Benzimidazol derivatives modulate chemokine receptors
09/26/2002CA2440632A1 Metalloproteinase inhibitors
09/26/2002CA2440475A1 Metalloproteinase inhibitors
09/26/2002CA2440106A1 Substituted benzopyranones as telomerase inhibitors
09/26/2002CA2404701A1 Triazole compounds having amide linkage
09/25/2002EP1242426A1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
09/25/2002EP1242417A1 Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents
09/25/2002EP1242416A1 Substituted isoxazolines and their use as antibacterial agents
09/25/2002EP1242414A1 Pyrazolyl benzyl ethers
09/25/2002EP1242413A1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels
09/25/2002EP1242412A2 3-(4,5-dihydroisoxazol-3-yl)-substituted benzoylpyrazoles
09/25/2002EP1242409A2 Substituted bisindolylmaleimides
09/25/2002EP1242407A1 Cyclic amp-specific phosphodiesterase inhibitors
09/25/2002EP1242403A1 2,4-diaminopyrimidine compounds usful as immunosuppressants
09/25/2002EP1242401A1 Cytotoxic agents comprising taxanes and their therapeutic use
09/25/2002EP1242400A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors
09/25/2002EP1242396A1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
09/25/2002EP1242394A1 Novel 3-oxo-2,1-benzisoxazol-1(3h)-carboxamides for treatment of cns diseases
09/25/2002EP1242385A1 Cytokine, especially tnf-alpha, inhibitors
09/25/2002EP1242076A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists
09/25/2002EP1144408B1 Substituted 1-(pieridin-4-yl)-3-(aryl) isothioureas their preparation and therapeutic application
09/25/2002EP1021405B1 Azetidinone derivatives for the treatment of hcmv infections
1 ... 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 ... 647